Lista de obras - Hugues Talbot - Dominio Público Uruguay

A Maximum-Flow Model for Digital Elastica Shape Optimization

artículo científico publicado en 2021

A deep learning model for the diagnosis of sacroiliitis according to Assessment of SpondyloArthritis International Society classification criteria with magnetic resonance imaging

artículo científico publicado en 2023

An Elastica-Driven Digital Curve Evolution Model for Image Segmentation

artículo científico publicado en 2020

Automated Image Analysis of In Vitro Angiogenesis Assay ⬇️

artículo científico publicado el 28 de junio de 2013

Automatic coronary artery calcium scoring from unenhanced-ECG-gated CT using deep learning

artículo científico publicado en 2021

Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Clinical validation of a computer-based approach for the quantification of the skin aging process of women using in-vivo confocal microscopy

artículo científico publicado en 2020

Continuous maximum flow segmentation method for nanoparticle interaction analysis ⬇️

artículo científico publicado el 28 de junio de 2011

Data from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Data from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Data from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Deep learning‐enabled imaging flow cytometry for high‐speed Cryptosporidium and Giardia detection

artículo científico publicado en 2021

Distributed algorithms for scalable proximity operator computation and application to video denoising

scientific article published in 2022

Does Super-Resolution Improve OCR Performance In The Real World? A Case Study On Images Of Receipts

artículo científico publicado en 2020

Efficient Position Estimation of 3D Fluorescent Spherical Beads in Confocal Microscopy via Poisson Denoising

artículo científico publicado en 2020

Generation of Patient-Specific Cardiac Vascular Networks: A Hybrid Image-Based and Synthetic Geometric Model

scientific article published on 15 August 2018

Generative adversarial networks (GAN)-based data augmentation of rare liver cancers: The SFR 2021 Artificial Intelligence Data Challenge

artículo científico publicado en 2023

Homotopic Affine Transformations in the 2D Cartesian Grid

artículo científico publicado en 2022

Incrementally Semi-Supervised Classification of Arthritis Inflammation on a Clinical Dataset

artículo científico publicado en 2022

Influence of Magnetic Field Strength on Magnetic Resonance Imaging Radiomics Features in Brain Imaging, an and Study

artículo científico publicado en 2020

Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients

artículo científico publicado en 2021

Machine Learning-Based Pipeline for High Accuracy Bioparticle Sizing

scientific article published on 07 December 2020

Machine‐Learning‐Assisted Intelligent Imaging Flow Cytometry: A Review

artículo científico publicado en 2021

Myocardial Perfusion Simulation for Coronary Artery Disease: A Coupled Patient-Specific Multiscale Model

artículo científico publicado en 2020

Object Detection With Component-Graphs in Multi-Band Images: Application to Source Detection in Astronomical Images

artículo científico publicado en 2021

Power Watershed: A Unifying Graph-Based Optimization Framework ⬇️

artículo científico publicado el 18 de noviembre de 2010

Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume

artículo científico publicado en 2022

Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker

artículo científico publicado en 2022

Rare bioparticle detection deep metric learning

artículo científico publicado en 2021

Shaping for PET image analysis

artículo científico publicado en 2020

Supplementary Figure S1 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S1 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S1 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S1 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S10 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S10 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S10 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S10 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S2 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S2 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S2 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S2 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S3 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S3 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S3 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S3 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S4 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S4 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S4 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S4 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S5 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S5 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S5 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S5 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S6 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S6 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S6 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S6 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S7 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S7 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S7 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S7 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S8 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S8 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S8 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S8 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S9 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S9 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S9 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Supplementary Figure S9 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

artículo científico publicado en 2023

Three-dimensional conditional random field for the dermal-epidermal junction segmentation

scientific article published on 29 April 2019

Toward semi-automatic biologically effective dose treatment plan optimisation for Gamma Knife radiosurgery

artículo científico publicado en 2022

Transformer Graph Network for Coronary Plaque Localization in CCTA

artículo científico publicado en 2022

Using Separated Inputs for Multimodal Brain Tumor Segmentation with 3D U-Net-like Architectures

artículo científico publicado en 2020

ZeBraInspector, a platform for the automated segmentation and analysis of body and brain volumes in whole 5 days post-fertilization zebrafish following simultaneous visualization with identical orientations

artículo científico publicado en 2022

n D Variational Restoration of Curvilinear Structures With Prior-Based Directional Regularization

artículo científico publicado en 2019

Lista de obras de Hugues Talbot

A Maximum-Flow Model for Digital Elastica Shape Optimization

A deep learning model for the diagnosis of sacroiliitis according to Assessment of SpondyloArthritis International Society classification criteria with magnetic resonance imaging

An Elastica-Driven Digital Curve Evolution Model for Image Segmentation

Automated Image Analysis of In Vitro Angiogenesis Assay ⬇️

Automatic coronary artery calcium scoring from unenhanced-ECG-gated CT using deep learning

Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Clinical validation of a computer-based approach for the quantification of the skin aging process of women using in-vivo confocal microscopy

Continuous maximum flow segmentation method for nanoparticle interaction analysis ⬇️

Data from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Data from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Data from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Deep learning‐enabled imaging flow cytometry for high‐speed Cryptosporidium and Giardia detection

Distributed algorithms for scalable proximity operator computation and application to video denoising

Does Super-Resolution Improve OCR Performance In The Real World? A Case Study On Images Of Receipts

Efficient Position Estimation of 3D Fluorescent Spherical Beads in Confocal Microscopy via Poisson Denoising

Generation of Patient-Specific Cardiac Vascular Networks: A Hybrid Image-Based and Synthetic Geometric Model

Generative adversarial networks (GAN)-based data augmentation of rare liver cancers: The SFR 2021 Artificial Intelligence Data Challenge

Homotopic Affine Transformations in the 2D Cartesian Grid

Incrementally Semi-Supervised Classification of Arthritis Inflammation on a Clinical Dataset

Influence of Magnetic Field Strength on Magnetic Resonance Imaging Radiomics Features in Brain Imaging, an and Study

Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients

Machine Learning-Based Pipeline for High Accuracy Bioparticle Sizing

Machine‐Learning‐Assisted Intelligent Imaging Flow Cytometry: A Review

Myocardial Perfusion Simulation for Coronary Artery Disease: A Coupled Patient-Specific Multiscale Model

Object Detection With Component-Graphs in Multi-Band Images: Application to Source Detection in Astronomical Images

Power Watershed: A Unifying Graph-Based Optimization Framework ⬇️

Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume

Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker

Rare bioparticle detection deep metric learning

Shaping for PET image analysis

Supplementary Figure S1 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S1 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S1 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S1 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S10 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S10 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S10 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S10 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S2 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S2 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S2 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S2 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S3 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S3 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S3 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S3 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S4 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S4 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S4 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S4 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S5 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S5 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S5 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S5 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S6 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S6 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S6 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S6 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S7 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S7 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S7 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S7 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S8 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S8 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S8 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S8 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S9 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S9 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S9 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Supplementary Figure S9 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Three-dimensional conditional random field for the dermal-epidermal junction segmentation

Toward semi-automatic biologically effective dose treatment plan optimisation for Gamma Knife radiosurgery

Transformer Graph Network for Coronary Plaque Localization in CCTA

Using Separated Inputs for Multimodal Brain Tumor Segmentation with 3D U-Net-like Architectures

ZeBraInspector, a platform for the automated segmentation and analysis of body and brain volumes in whole 5 days post-fertilization zebrafish following simultaneous visualization with identical orientations

n D Variational Restoration of Curvilinear Structures With Prior-Based Directional Regularization